qualification requirements intact and adjust the licensing fee structure to prevent overburdens to business operators.Essentially, this approach would allow an applicant to apply for a package of licenses at one

- 2020 Balance by Quarter Change Q2–20 Q1–20 Q2–19 Q2–20 VS Q1–20 Q2–20 VS Q2–19 (Million Baht: MB) (MB) % (MB) % Total Revenue 1,187.6 1,231.7 1,729.6 (44.1) (3.6) (542.0) (31.3) Total Operating Expenses

granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures

Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales

Q3–2020 Balance by Quarter Change Q3–20 Q2–20 Q3–19 Q3–20 VS Q2–20 Q3–20 VS Q3–19 (Million Baht: MB) (MB) % (MB) % Total Revenue 2,241.1 1,187.6 1,798.9 1,053.5 88.7 442.2 24.6 Total Operating Expenses

Three Months period ended 31 December (3M YoY) Sales by geography Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 31 December 2018 2019 THB mm % THB mm % THB mm

. Table 1 : Sales Revenue by Product Line for the Three Months period ended 30 June (3M YoY) Sales by geography Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30

effective since 1 January 2019. Table 1 : Sales Revenue by Product Line for the Three Months period ended 30 September (3M YoY) Sales by geography Consolidated financial statements Change Increase/(Decrease

processes throughout the Company. 4. Financial Position of the Company and its Subsidiaries Unit : Million Baht 31/3/2020 31/12/2019 % change Cash and cash equivalents 100 119 (16%) Account receivables 828